This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Clinical HIV Research Unit | |
|---|---|
| Name | Clinical HIV Research Unit |
| Established | 1990s |
| Location | Johannesburg, South Africa |
| Type | Clinical research center |
| Affiliations | University of the Witwatersrand, National Institutes of Health, South African Medical Research Council |
| Focus | Human immunodeficiency virus research, clinical trials, antiretroviral therapy |
Clinical HIV Research Unit The Clinical HIV Research Unit is a clinical research center specializing in human immunodeficiency virus studies, antiretroviral therapy evaluation, and translational medicine. It operates within academic and public health networks including University of the Witwatersrand, South African Medical Research Council, National Institutes of Health, and partners in global health initiatives such as World Health Organization and UNAIDS. The unit conducts interventional and observational studies in contexts shaped by institutions like Baragwanath Hospital, Chris Hani Baragwanath Hospital, Lancet-affiliated collaborations, and multinational trials with sponsors such as Bill & Melinda Gates Foundation and Wellcome Trust.
The unit functions as a nexus between clinical care at sites like Helen Joseph Hospital and translational research hubs including Imperial College London and Harvard University. It integrates epidemiology influenced by Joint United Nations Programme on HIV/AIDS, laboratory science connecting to Africa Health Research Institute, and biostatistics collaborations with Johns Hopkins Bloomberg School of Public Health. Core activities include antiretroviral drug evaluation associated with pharmaceutical partners such as Gilead Sciences, ViiV Healthcare, and Merck & Co., as well as vaccine platform research linked to Moderna, Pfizer, and AstraZeneca.
The unit emerged during the expansion of HIV research in southern Africa in the 1990s, paralleling initiatives by Clinton Presidential HIV/AIDS Initiative, PEPFAR, and research networks like International AIDS Society. Early collaborations involved clinicians and researchers from University of Cape Town, Stellenbosch University, and University of KwaZulu-Natal, and were influenced by seminal trials at sites connected to Fred Hutchinson Cancer Research Center and University of California, San Francisco. Milestones include participating in antiretroviral rollout studies with agencies such as South African Department of Health and global funders like The Global Fund.
Programs emphasize antiretroviral therapy optimization involving drugs from Gilead Sciences, ViiV Healthcare, and Johnson & Johnson, prevention research linked to Centers for Disease Control and Prevention, and co-infection studies with World Health Organization guidance on tuberculosis and HIV. The unit conducts pediatric HIV research alongside institutions like Boston Children's Hospital and maternal health studies related to Elizabeth Glaser Pediatric AIDS Foundation. Basic science interfaces with immunology groups at Max Planck Institute for Infection Biology and vaccine research consortia involving University of Oxford and Karolinska Institutet.
Clinical trial design follows standards set by Good Clinical Practice, overseen by ethics boards aligned with South African Health Products Regulatory Authority and monitored according to protocols used in trials by International Conference on Harmonisation. The unit has implemented randomized controlled trials mirroring designs from National Institutes of Health-funded studies and adaptive platform trials inspired by RECOVERY Trial methodology. Data management and biostatistics draw on collaborations with London School of Hygiene & Tropical Medicine and University of Washington.
Partnerships span universities including University of the Witwatersrand, University of Cape Town, and Harvard University; funders such as Wellcome Trust and Bill & Melinda Gates Foundation; and global health agencies like WHO and UNAIDS. Networked research connects to consortia such as HIV Vaccine Trials Network and AIDS Clinical Trials Group, and engages with pharmaceutical partners Gilead Sciences and ViiV Healthcare. Implementation science links include collaborations with Clinton Health Access Initiative and Medicines Patent Pool.
Ethical oversight involves institutional review boards modeled after protocols from World Health Organization and Council for International Organizations of Medical Sciences. Regulatory submissions adhere to frameworks from South African Health Products Regulatory Authority, European Medicines Agency, and U.S. Food and Drug Administration. Community engagement strategies reflect principles championed by Treatment Action Campaign and community advisory boards like those used in International AIDS Conference-linked community research.
Facilities include clinical wards connected to Chris Hani Baragwanath Hospital, laboratory infrastructure meeting standards of National Institute for Communicable Diseases (South Africa), and bioinformatics capacity collaborating with H3Africa. Laboratory platforms encompass virology, immunology, and pharmacology units comparable to those at Africa Centres for Disease Control and Prevention partner sites. Cold chain and manufacturing partnerships interface with organizations such as South African Vaccines and Biomanufacturing Institute and regional biobanks.
The unit has contributed to antiretroviral treatment guidelines influenced by findings disseminated through journals like The Lancet, New England Journal of Medicine, and Nature Medicine. Its trials have informed policy decisions at South African Department of Health and international programs including PEPFAR and The Global Fund. Notable contributions include data on treatment-as-prevention strategies relevant to HIV Prevention Trials Network outcomes and implementation research that shaped practices advocated by World Health Organization and UNAIDS.
Category:HIV/AIDS research organizations